The group’s principal activity is to develop medical devices. Products of the group include CytoSorb(TM) and BetaSorb(TM). In June 2006, the group acquired MedaSorb Technologies, Inc. and MedaSorb Acquisition Inc. The group operates from North America, Europe, Latin America and the Asia Pacific.
